Shanghai based Active Intelligence Technologies announced a CNY 464 million angel plus round on 4 November 2026. Gaorong Ventures, SSCI Leading Fund and Shanghai STVC Group co led the financing, with additional institutional investors participating. The company develops artificial intelligence systems for medical and life science applications. Its work combines specialised models, scientific data and software intended to support research and clinical workflows. The capital will support technology development, team growth and product deployment. Multiple independent Chinese investment publications reported the amount and co leads, while a direct company announcement was not located during this run.
Active Intelligence raises CNY 464m
Three investors co lead medical AI angel round

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


